TrialClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2014

Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.

J P Arm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.